Ignite Creation Date:
2024-05-06 @ 1:33 PM
Last Modification Date:
2024-10-26 @ 1:16 PM
Study NCT ID:
NCT04055493
Status:
RECRUITING
Last Update Posted:
2023-05-15
First Post:
2019-07-22
Brief Title:
Adj Marker-adjusted Personalized Therapy Comparing ETRibociclib vs Chemotherapy in Intermediate Risk HRHER2- EBC
Sponsor:
West German Study Group
Organization:
West German Study Group
Organization Data
Organization:
West German Study Group
Class:
OTHER
Study ID:
WSG-AM08
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
West German Study Group
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Genomic Health Inc | INDUSTRY |
| Novartis | INDUSTRY |